To compare the 3-year outcome of Ex-PRESS miniature glaucoma shunt versus Ahmed glaucoma valve in pseudophakic patients.
We retrospectively reviewed the records of patients with a history of clear-corneal phacoemulsification alone, or failed trabeculectomy following phacoemulsification who subsequently underwent AGV implantation or Ex-PRESS shunt surgery. The main outcome measure, surgical success, was defined as an IOP between 5mmHg and 21▒mm Hg and a 20% IOP reduction from baseline (with/ without glaucoma medications) without glaucoma reoperation.
Ninety two patients (92 eyes) were included (43 AGV, 49 Ex-PRESS). Overall success at 3 years was 92.7% for AGV and 66.1% for Ex-PRESS (P = 0.006). AGV had a higher success rate in patients with prior phacoemulsification and failed trabeculectomy (96% AGV vs. 64.1% Ex-PRESS, P= 0.023). There was no difference in success rate for patients with only previous phacoemulsification. (87.5% AGV vs. 69.4% Ex-PRESS, P = 0.205 ). Glaucoma reoperation rates were 4.6% and 30.6% in the AGV and Ex-PRESS group respectively (P=0.001). Both procedures had similar complication rates.
AGV compared with Ex-PRESS shunt, had a higher success rate for secondary surgeries but not primary surgeries, in patients with prior clear-corneal phacoemulsification, The AGV surgery also had a lower overall glaucoma reoperation rate.
*Department of Ophthalmology Carmel Medical Center, Haifa, Israel, affiliated to the Rapaport Faculty of Medicine, The Technion, Haifa, Israel
†Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA
‡Community Medicine and Epidemiology,Carmel Medical Center, Haifa, Israel
§Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel
Financial Support: None.
Beth Edmunds is supported by an unrestricted grant from Research to Prevent Blindness.
Précis: In pseudophakic patients, Ahmed glaucoma valve implantation is superior for secondary surgeries but not primary surgeries, compared with Ex-PRESS surgery,
No conflicting relationship exists for any author.
Reprints: Orna Geyer, MD, Head, Department of Ophthalmology, Carmel Medical Center, 7 Michal Street, Haifa, 34362, Israel (e-mail: firstname.lastname@example.org).
Received March 17, 2018
Accepted August 1, 2018